Article
Canaccord Genuity Maintains Buy on Hinge Health, Lowers Price Target to $53
Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and lowers the price target from $65 to $53.
Comments
- No comments yet. Be the first to comment!